Navigation Links
Seeing your true colors: Standards for hyperspectral imaging
Date:7/1/2014

Today, doctors who really want to see if a wound is healing have to do a biopsy or some other invasive technique that, besides injuring an already injured patient, can really only offer information about a small area. But a technology called hyperspectral imaging offers doctors a noninvasive, painless way to discriminate between healthy and diseased tissue and reveal how well damaged tissue is healing over a wide area. The catch? A lack of calibration standards is impeding its use.

After a successful non-human trial, researchers at the National Institute of Standards and Technology (NIST) have started gathering data on how human skin looks under various wavelengths of light in order to develop these badly needed standards.*

Unlike consumer digital cameras and the human eye, which only see red, green and blue light, a relatively narrow portion of the electromagnetic spectrum, each pixel of a hyperspectral image captures information for hundreds of narrow spectral bandsfrom the ultraviolet to the infrared.

According to NIST researcher David Allen, being sensitive to so many wavelengths means hyperspectral imagers can see many different things that humans can't see, including the amount of oxygen in human tissues, an indicator of healing.

"The potential of the technology has been proven, but the problem is that researchers are simply lacking a way to assure consistent results between labs," says Allen. "Standards development has itself been hindered by a lack of human skin reflectance data, especially in the ultraviolet and short-wave infrared."

Catherine Cooksey, the project leader for the spectrophotometry program that establishes and maintains the national scale of reflectance, says that before we delve into what diseased tissue looks like hyperspectrally, we need to know what so-called "normal" tissue looks like. Furthermore, she says that they are looking to quantify the variability both within an individual and between individuals due to inherent biological differences. The initial NIST studies used 28 volunteer test subjects. The data collected included a photograph of the test area on the subject's forearm and three reflectance measurements of the test area.

"Skin reflectance varies due to skin pigmentation, tissue density, lipid content and blood volume changes," says Cooksey. "And few, if any, studies of skin reflectance have been done with an estimated measurement uncertainty that is traceable to NIST or any other national metrology institute. We need good data from a wide variety of sources, and for that we need the help of our colleagues in the community."

Once they collect enough data, the NIST researchers can feed it into NIST's Hyperspectral Image Projector, a device that creates hyperspectral scenes that have all the spectral signatures of the real thingin this case, tissue in various stages of repair. Medical imaging technicians can then use these "digital tissue phantoms" to test their imagers' ability to discern among and detect different tissue types and conditions.


'/>"/>

Contact: Mark Esser
mark.esser@nist.gov
301-975-8735
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related medicine news :

1. Seeing fewer older people in the street may lead low-income adults to fast-track their lives
2. Seeing is believing: Biologists and physicists produce revealing images of cell organization, behavior
3. Seeing through HIVs disguises
4. Merrill DataSite Releases New Comments: Solar technology M&A financing seeing shift in strategy
5. Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children
6. Vein Specialties Seeing Younger Clientele with Venous Disorders
7. Transvaginal Mesh Lawsuit News: Federal Judge Overseeing Boston Scientific Vaginal Mesh Lawsuits Selects Bellwether Cases, Bernstein Liebhard LLP Reports
8. Certified Nurse Midwives of Women's Excellence in Midwifery Now Seeing Teens for Gynecological Care in Lake Orion and Clarkston, Michigan Locations
9. Pacific Prime Clients With AXA PPP Seeing Modest Premium Adjustment
10. Pacific Prime Clients with Allianz Seeing Modest Increase in Health Insurance Premiums
11. Vaginal Mesh Lawsuit News: Federal Judge Overseeing American Medical Systems Litigation Sets Order of First Bellwether Trials, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Seeing your true colors: Standards for hyperspectral imaging
(Date:4/29/2017)... ... April 29, 2017 , ... More than half of Americans suffering from noise-induced ... their leisure time that causes hearing loss? May 1 marks the beginning of Better ... hearing loss, as well as schedule a hearing evaluation for anyone with concerns about ...
(Date:4/28/2017)... Cary, NC (PRWEB) , ... April 28, 2017 ... ... to announce its new partnership with the Home Care Association of America (HCAOA). ... Hospice, and Private Duty Accreditation services, as well as discounts on Accreditation University ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of ... rating of “A” and its outlook as “stable.” At the same time, the ratings ... fallen in recent years, dip below “capital adequacy” thresholds required for its strong rating. ...
(Date:4/28/2017)... ... 28, 2017 , ... Ushio America proudly introduces the new ... energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts ... rated lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s ...
(Date:4/28/2017)... Texas (PRWEB) , ... April 28, 2017 , ... The ... plaque in recently to the labor and delivery team at Women’s Hospital at Renaissance ... mothers who give birth at the hospital and decide to donate. , “Women’s ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: